GH1 and Anxiety: These low adherence rates for r-hGH treatment may be the result of insufficient knowledge about the disease and its treatment, the need for daily injections from childhood to late adolescence, discomfort and pain associated with daily injections, treatment beliefs, treatment-related anxiety, a lack of self-efficacy, or concerns about long-term treatment (3).